Роль метаболической хирургии в лечении пациентов с кардиоренометаболическим синдромом
https://doi.org/10.31146/1682-8658-ecg-235-3-261-269
Аннотация
Об авторах
Л. А. ШароноваРоссия
С. В. Булгакова
Россия
Д. А. Чичерина
Россия
О. В. Косарева
Россия
Ю. А. Долгих
Россия
П. Я. Мерзлова
Россия
Е. В. Тренева
Россия
Д. П. Курмаев
Россия
А. А. Шаронова
Россия
Список литературы
1. Oganov R.G., Simanenkov V.I., Bakulin I.G. et al.Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66. (In Russ.) doi: 10.15829/1728-8800-2019-1-5-66.@@ Оганов Р.Г., Симаненков В.И., Бакулин И.Г. и соавт. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019;18(1):5-66. doi: 10.158 29/1728-8800-2019-1-5-66.
2. Ndumele Ch.E., Neeland I.J., Tuttle K.R. et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. 9 Oct. 2023. Circulation. 2023;148:1636-64. doi: 10.1161/CIR.0000000000001186.
3. Polozova E.I., Sorokina N.N. Cardiorenal continuum in metabolic syndrome. Modern problems of science and education. 2019;2:118. (in Russ.)@@ Полозова Э.И., Сорокина Н.Н. Кардиоренальный континуум при метаболическом синдроме. Современные проблемы науки и образования. Проблемы науки и образования. 2019;2:118.
4. Arabidze G.G., Mamedov M.N. Cardiovascular-kidney-metabolic syndrome - a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue.Russian Journal of Cardiology. 2024;29(5):5772. (In Russ.) doi: 10.15829/1560-4071-2024-5772.@@ Арабидзе Г.Г., Мамедов М.Н. Кардиоваскулярно-почечно-метаболический синдром - новая концепция ассоциациифакторов риска и нарушений обмена в рамках сердечно-сосудистого и почечного континуума. Мнение по проблеме. Российский кардиологический журнал. 2024;29(5):5772. doi: 10.15829/1560-4071-2024-5772.
5. Bobkova I.N., Gussaova S.S., Stavrovskaya E.V., Struve A.V. Nephrological aspects of surgical weight correction in morbid obesity. Terapevticheskii arkhiv. 2018;90(6):98-104. doi: 10.26442/terarkh201890698-104.@@ Бобкова И.Н., Гуссаова С.С., Ставровская Е.В., Струве А.В. Нефрологические аспекты хирургической коррекции массы тела при морбидном ожирении. Терапевтический архив. 2018;90(6):98-104. doi: 10.26442/terarkh201890698-104.
6. Galagudza M.M., Neimark A.E., Kornyushin O.V. Metabolic surgery: from history to real achievements. Experimental and Clinical Gastroenterology. 2022;198(2): 86-102. (In Russ.) doi: 10.31146/1682-8658-ecg-198-2-86-102.@@ Галагудза М.М., Неймарк А.Е., Корнюшин О.В. Метаболическая хирургия: от истории к реальным достижениям. Экспериментальная и клиническая гастроэнтерология. 2022;198(2): 86-102. doi: 10.31146/1682-8658-ecg-198-2-86-102.
7. Baker M.T. The history and evolution of bariatric surgical procedures. Surg Clin North Am. 2011;91(6): 1181-1201. doi: 10.1016/j.suc.2011.08.002.
8. Henrikson V. Can Small Bowel Resection Be Defended as Therapy for Obesity? Obes Surg. 1994;4(1):54-54. doi: 10.1381/096089294765558926.
9. Kremen A.J., Linner J.H., Nelson C.H. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140(3):439-448. doi: 10.1097/00000658-195409000-00018.
10. Lewis L.A., Turnbull R.B. Jr, Page I.H. “Short-circuiting” of the small intestine. Effect on concentration of serum cholesterol and lipoproteins. JAMA. 1962;182:77-79. doi: 10.1001/jama.1962.03050400079017b.
11. Buchwald H. Lowering of cholesterol absorption and blood levels by ileal exclusion. experimental basis and preliminary clinical report. Circulation. 1964;29:713-720. doi: 10.1161/01.cir.29.5.713.
12. Fock K.M., Khoo J. Diet and exercise in management of obesity and overweight. J Gastroenterol Hepatol. 2013;28 Suppl 4:59-63. doi: 10.1111/jgh.12407.
13. Catona A., Gossenberg M., La Manna A., Mussini G. Laparoscopic Gastric Banding: preliminary series. Obes Surg. 1993;3(2):207-209. doi: 10.1381/096089293765559610.
14. Wilkinson L.H., Peloso O.A. Gastric (reservoir) reduction for morbid obesity. Arch Surg. 1981;116(5):602-605. doi: 10.1001/archsurg.1981.01380170082014.
15. Laws H.L. Standardized gastroplasty orifice. Am J Surg. 1981;141(3):393-394. doi: 10.1016/0002-9610(81)90206-3.
16. Scopinaro N., Gianetta E., Civalleri D., Bonalumi U., Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618-620. doi: 10.1002/bjs.1800660906.
17. Vasilevsky D.I., Sedletsky Yu.I., Аnisimova К.А., Davletbaeva L.I. History of surgical treatment of obesity and metabolic disorders. Pediatrician (St. Petersburg). 2018;9(4):87-104. doi: 10.17816/PED9487-104.@@ Василевский Д.И., Седлецкий Ю.И., Анисимова К.А., Давлетбаева Л.И. История хирургического лечения ожирения и метаболических нарушений // Педиатр. 2018;9(4):87-104. doi: 10.17816/PED9487-104.
18. Nieben O.G., Harboe H.Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1(8265):198-199. doi: 10.1016/s0140-6736(82) 90762-0.
19. Johnston D., Dachtler J., Sue-Ling H.M. et al. The Magenstrasse and Mill Operation for Morbid Obesity. Obes Surg. 2003;13(1):10-16. doi: 10.1381/09608 9203321136520.
20. Anderson B., Gill R.S., de Gara C.J., Karmali S., Gagner M. Biliopancreatic diversion: the effectiveness of duodenal switch and its limitations. Gastroenterol Res Pract. 2013;2013:974762. doi: 10.1155/2013/974762.
21. Polyakov A.A., Soloviev A.O., Bessonov K.A., Vorobyova A.A. Recent advancements in bariatric surgery for obesity treatment.Russian Journal of Evidence-Based Gastroenterology. 2023;12(3):79-87. (In Russ.) doi: 10.17116/dokgastro20231203179.@@ Поляков А.А., Соловьев А.О., Бессонов К.А., Воробьёва А.А. Современные представления о бариатрической хирургии как о методе лечения ожирения. Доказательная гастроэнтерология. 2023;12(3):79-87. doi: 10.17116/dokgastro20231203179.
22. Crossan K., Sheer A.J.Intragastric Balloon. 2023 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
23. Seeras K., Sankararaman S., Lopez P.P. Sleeve Gastrectomy. 2023 Jan 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
24. Felsenreich D.M., Langer F.B., Kefurt R. et al. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(9):1655-1662. doi: 10.1016/j.soard.2016.02.021.
25. Genco A., Soricelli E., Casella G. et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568-574. doi: 10.1016/j.soard.2016.11.029.
26. Felsenreich D.M., Kefurt R., Schermann M. et al. Reflux, Sleeve Dilation, and Barrett’s Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up. Obes Surg. 2017;27(12):3092-3101. doi: 10.1007/s11695-017-2748-9.
27. Van Hee R.H. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg. 2004;28(5):435-444. doi: 10.1007/s00268-004-7364-x.
28. Marceau P., Biron S., Hould F.S. et al. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis. 2009;5(1):43-47. doi: 10.1016/j.soard.2008.03.244.
29. Ospanov O.B., Yeleuov G.A., Bekmurzinova F.K. Gastric bypass in modern bariatric surgery. Obesity and metabolism. 2020;17(2):130-137. (In Russ.) doi: 10.14341/omet10161.@@ Оспанов О.Б., Елеуов Г.А., Бекмурзинова Ф.К. Желудочное шунтирование в современной бариатрической хирургии. Ожирение и метаболизм. 2020;17(2):130-137. doi: 10.14341/omet10161.
30. Musella M., Milone M. Still «controversies» about the mini gastric bypass? Obes Surg. 2014;24(4):643-644. doi: doi: 10.1007/s11695-014-1193-2.
31. Rutledge R., Kular K., Manchanda N. The Mini-Gastric Bypass original technique.Int J Surg. 2019;61:38-41. doi: doi: 10.1016/j.ijsu.2018.10.042.
32. D’hoedt A., Vanuytsel T. Dumping syndrome after bariatric surgery: prevalence, pathophysiology and role in weight reduction - a systematic review. Acta Gastroenterol Belg. 2023;86(3):417-427. doi: 10.51821/86.3.11476.
33. Hedberg S., Thorell A., Österberg J. et al.Comparison of Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass: A Randomized Clinical Trial [published correction appears in JAMA Netw Open. 2024 Mar 4;7(3): e248600. doi: 10.1001/jamanetworkopen.2024.8600]. JAMA Netw Open. 2024;7(1): e2353141. Published 2024 Jan 2. doi: 10.1001/jamanetworkopen.2023.53141.
34. Buchwald H., Varco R. Metabolic surgery. New York: Grune & Stratton; 1978
35. Cummings D.E., Cohen R.V. Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol. 2014;2(2):175-181. doi: 10.1016/S2213-8587(13)70198-0.
36. Cohen R., Pechy F., Petry T. et al. Bariatric and metabolic surgery and microvascular complications of type 2 diabetes mellitus. J Bras Nefrol. 2015;37(3):399-409. doi: 10.5935/0101-2800.20150061.
37. Sjöström L., Peltonen M., Jacobson P. et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56-65. doi: 10.1001/jama.2011.1914.
38. Pané A., Claro M., Molina-Andujar A., Olbeyra R. et al. Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease. Journal of Clinical Medicine. 2023; 12(18):6095. doi: 10.3390/jcm12186095.
39. Fathy E., Aisha H., Abosayed A. et al. Effect of Bariatric Surgery on Albuminuria in Non-Diabetic Non-Hypertensive Patients with Severe Obesity: a Short-Term Outcome. OBES SURG. 2022;32:2397-2402. doi: 10.1007/s11695-022-06091-z.
40. Wee Z., Ganguly S., Tham K.W., Lim C.H., Tan J.T.H., Lee P.C. Renal Outcomes 1 Year After Metabolic Bariatric Surgery in a Multi-ethnic Asian Cohort. Obes Surg. 2021;31:5358-5366 doi: 10.1007/s11695-021-05732-z.
41. Lee Y., Anvari S., Chu M.M. et al. Improvement of kidney function in patients with chronic kidney disease and severe obesity after bariatric surgery: A systematic review and meta-analysis. Nephrology (Carlton). 2022;27:44-56. doi: 10.1111/nep.13958.
42. Funes D.R., Montorfano L., Blanco D.G., Cobos M.S., Lo Menzo E., Szomstein S., Agrawal N., Rosenthal R.J. Sleeve gastrectomy in patients with severe obesity and baseline chronic kidney disease improves kidney function independently of weight loss: a propensity score matched analysis. Surg Obes Relat Dis. 2022;18:772-778. doi: 10.1016/j.soard.2022.02.006.
43. Sandino J., Martín-Taboada M., Medina-Gómez G., Vila-Bedmar R., Morales E. Novel Insights in the Physiopathology and Management of Obesity-Related Kidney Disease. Nutrients. 2022;14: 3937. doi: 10.3390/nu14193937.
44. Morales E., Porrini E., Martin-Taboada M. et al. Renoprotective role of bariatric surgery in patients with established chronic kidney disease. Clin Kidney J. 2021;14:2037-2046. doi: 10.1093/ckj/sfaa266.
45. Theofilis P., Vordoni A., Kalaitzidis R.G.Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations. World J Gastroenterol. 2022; 28(39): 5691-5706. doi: 10.3748/wjg.v28.i39.5691.
46. McIsaac M., Kaban G., Clay A. et al. Long-term impact of bariatric surgery on renal outcomes at a community-based publicly funded bariatric program: the Regina bariatric study. Can J Kidney Health Dis. 2019;6:2054358119884903. doi: 10.1177/2054358119884903.
47. Bilha S.C., Nistor I., Nedelcu A. et al. The effects of bariatric surgery on renal outcomes: a systematic review and meta-analysis. Obes Surg. 2018;28:3815-33. doi: 10.1007/s11695-018-3416-4.
48. Fenske W.K., Dubb S., Bueter M. et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9:559-68. doi: 10.1016/j.soard.2012.03.009.
49. Lee Y., Raveendran L., Lovrics O. et al. The role of bariatric surgery on kidney transplantation: A systematic review and meta-analysis. Can. Urol. Assoc. J. 2021;15: E553-E562. doi: 10.5489/cuaj.7109.
50. Schiavon C.A., Bersch- Ferreira A.C., Santucci E.V. et al. Effects of bariatric surgery in obese patients with hypertension: the gateway randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137:1132-42. doi: 10.1161/CIR.0000000000000577.
51. Ortiz- Gomez C., Romero- Funes D., Gutierrez- Blanco D. et al. Impact of rapid wei ght loss aft er bariatric surgery on the prevalence of arterial hypertension in severely obese patients with chronic kidney disease. Surg Endosc. 2019 Sep 6. doi: 10.1007/s00464-019-07094-1.
52. Głuszewska A., Gryglewska B., Gąsowski J. et al. Reduction of 24-h blood pressure variability in extreme obese patients 10 days a nd 6 months aft er bariatric surgery depending on pre-existing hypertension. Eur J Intern Med. 2019 Feb;60:39-45. doi: 10.1016/j.ejim.2018.10.022.
53. Dedov I.I., Mokrysheva N.G., Mel’nichenko G.A. et al. Obesity. Clinical guidelines. Consilium Medicum. 2021; 23 (4): 311-325. (in Russ.) doi: 10.26442/20751753.2021.4.200832.@@ Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А. и др. Ожирение. Клинические рекомендации. Consilium Medicum. 2021; 23 (4): 311-325. doi: 10.26442/20751753.2021.4.200832.
54. Horwitz D., Padron C., Kelly T. et al. Long-term outcomes comparing metabolic surgery to no surgery in patients with type 2 diabetes and body mass index 30-35. Surg Obes Relat Dis. 2020;16(4):503-8. doi: 10.1016/j.soard.2020.01.016.
55. Zhou X., Zeng C. Diabetes remission of bariatric surgery and nonsurgical treatments in type 2 diabetes patients who failure to meet the criteria for surgery: a systematic review and meta-analysis. BMC Endocr Disord. 2023;23:46. doi: 10.1186/s12902-023-01283-9.
56. Balasubaramaniam V., Pouwels S. Remission of Type 2 Diabetes Mellitus (T2DM) after Sleeve Gastrectomy (SG), One-Anastomosis Gastric Bypass (OAGB), and Roux-en-Y Gastric Bypass (RYGB): A Systematic Review. Medicina (Kaunas). 2023;59(5):985. Published 2023 May 19. doi: 10.3390/medicina59050985.
57. Sjöström L.J. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J.Intern. Med. 2013; 273 (3): 219-234. doi: 10.1111/joim.12012.
58. Syn N.L., Cummings D.E., Wang L.Z. et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: A one-stage meta-analysis of matched cohort and prospective controlled studies with 174,772 participants. Lancet. 2021;397:1830-1841. doi: 10.1016/S0140-6736(21)00591-2.
59. Aminian A., Zajichek A., Arterburn D.E. et al. Association of Metabolic Surgery with Major Adverse Cardiovascular Outcomes in Patients with Type 2 Diabetes and Obesity. JAMA-J. Am. Med. Assoc. 2019;322:1271-1282. doi: 10.1001/jama.2019.14231.
60. Funes D.R., Blanco D.G., Gómez C.O. et al. Metabolic surgery reduces the risk of progression from chronic kidney disease to kidney failure. Ann Surg. 2019; 270:511-8. doi: 10.1097/SLA.0000000000003456).
61. Cheng Y.L., Elli E.F. Outcomes of Bariatric Surgery After Solid Organ Transplantation. Obes Surg. 2020 Dec;30(12):4899-4904. doi: 10.1007/s11695-020-05013-1.
62. Huang H., Lu J., Dai X. et al. Improvement of Renal Function After Bariatric Surgery: A Systematic Review and Meta-analysis. Obes. Surg. 2021;31:4470-4484. doi: 10.1007/s11695-021-05630-4.
63. Chang A.R., Grams M.E., Navaneethan SD. Bariatric surgery and kidney-related outcomes. Kidney Int Rep. 2017;2:261-70. doi: 10.1016/j.ekir.2017.01.010.
64. Khajeh E., Aminizadeh E., Dooghaie Moghadam A. et al. Bariatric surgery in patients with obesity and end-stage renal disease. Surg Obes Relat Dis. 2023 Aug;19(8):858-871. doi: 10.1016/j.soard.2023.01.015.
65. Montgomery J.R., Cohen J.A., Brown C.S., Sheetz K.H., Chao G.F., Waits S.A., Telem D.A. Perioperative risks of bariatric surgery among patients with and without history of solid organ transplant. Am J Transplant. 2020 Sep;20(9):2530-2539. doi: 10.1111/ajt.15883.
66. Abdullah H.R., Tan T.P., Vaez M. et al. Predictors of perioperative acute kidney injury in obese patients undergoing laparoscopic bariatric surgery: a single-centre retrospective cohort study. Obes Surg. 2016;26:1493-9. doi: 10.1007/s11695-015-1938-6.
67. Lieske J.C., Mehta R.A., Milliner D.S. et al. Kidney stones are common after bariatric surgery. Kidney Int. 2015;87:839-45. doi: 10.1038/ ki.2014.352.
Рецензия
Для цитирования:
Шаронова Л.А., Булгакова С.В., Чичерина Д.А., Косарева О.В., Долгих Ю.А., Мерзлова П.Я., Тренева Е.В., Курмаев Д.П., Шаронова А.А. Роль метаболической хирургии в лечении пациентов с кардиоренометаболическим синдромом. Экспериментальная и клиническая гастроэнтерология. 2025;(3):261-269. https://doi.org/10.31146/1682-8658-ecg-235-3-261-269
For citation:
Sharonova L.A., Bulgakova S.V., Chicherina D.A., Kosareva O.V., Dolgikh Yu.A., Merzlova P.Ya., Treneva E.V., Kurmaev D.P., Sharonova A.A. The role of metabolic surgery in the treatment of patients with cardiorenometabolic syndrome. Experimental and Clinical Gastroenterology. 2025;(3):261-269. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-235-3-261-269
 
                    
 
                                                 


































 
             
  Послать статью по эл. почте
            Послать статью по эл. почте